Skip to main content

AI assistant

Sign in to chat with this filing

The assistant answers questions, extracts KPIs, and summarises risk factors directly from the filing text.

CRH PLC Regulatory Filings 2021

Mar 25, 2021

1980_ffr_2021-03-25_6a306cd5-fc81-4702-a21b-656517b4a2f9.zip

Regulatory Filings

Open in viewer

Opens in your device viewer

6-K 1 a4764t.htm TRANSACTION IN OWN SHARES Document created using Blueprint(R) - powered by Issuer Direct - www.issuerdirect.com Copyright 2021 Issuer Direct Corporation a4764t

UNITED STATES

SECURITIES AND EXCHANGE COMMISSION

Washington, DC 20549

FORM 6-K

REPORT OF FOREIGN PRIVATE ISSUER

PURSUANT TO RULE 13A - 16 OR 15D - 16 OF

THE SECURITIES EXCHANGE ACT OF 1934

25 March 2021

Commission File No. 001-32846


CRH public limited company

(Translation of registrant's name into English)


Belgard Castle, Clondalkin,

Dublin 22, Ireland.

(Address of principal executive offices)


Indicate by check mark whether the registrant files or will file annual reports

under cover of Form 20-F or Form 40-F:

Form 20-F X Form 40-F___

Indicate by check mark if the registrant is submitting the Form 6-K in paper as permitted by

Regulation S-T Rule 101(b)(1): ___

Indicate by check mark if the registrant is submitting the Form 6-K in paper as permitted by

Regulation S-T Rule 101(b)(7):__

Enclosure: Transaction in Own Shares

25 th March 2021

RE-ISSUE OF TREASURY SHARES

CRH plc announces that it has transferred to the Trustees of the CRH plc Employee Benefit Trust 2,918,381 Ordinary Shares at a price of €37.92 per Ordinary Share for the purpose of satisfying vested awards made under the CRH 2014 Performance Share Plan.

Following the above transactions, CRH plc holds 8,444,772 Ordinary Shares in Treasury. The number of Ordinary Shares in issue (excluding Treasury Shares) is 786,695,566.

Contact

Diarmuid Enright

Assistant Company Secretary

Tel: 00 3531 6344340


SIGNATURE

Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned, thereunto duly authorized.

(Registrant )
Date 25
March 2021
By:___/s/Neil
Colgan___
N.Colgan
Company Secretary

page break